Tag: biologics manufacturing
OneSource Specialty Pharma, Formycon enter strategic manufacturing partnership for biosimilars
OneSource Specialty Pharma has entered into a strategic manufacturing partnership with Germany-based biosimilar developer Formycon AG to support the manufacture of biosimilar medicines for global markets.
Enzene appoints Norm Stoffregen to lead new U.S. biomanufacturing facility
Stoffregen will oversee commissioning and expand operations at Enzene's $50 million biologics manufacturing facility in Hopewell, NJ